文献速递湿疹皮炎与荨麻疹

年轻成人特应性皮炎的药物利用:性别、社会经济状况与疾病严重程度的影响

Drug utilization among young adults with atopic dermatitis: Influence of sex, socio-economic status and disease severity.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2024-05-06

基于BAMSE出生队列24年随访(n=2912)的横断面研究,链接国家药品登记数据,分析年轻成人特应性皮炎(AD)的药物利用。AD患病率17.7%(n=516),45.5%在研究期间至少配取一种AD治疗药物。男性及中重度AD与外用糖皮质激素(TCS)配取相关,无人配取推荐量的润肤剂。

要点

  • 年轻成人AD患病率17.7%,45.5%配取至少一种AD药物。
  • 男性及中重度AD与TCS配取独立相关(adj.OR 1.54和2.62)。
  • 无人配取推荐量的润肤剂,轻度AD中不足5人配取推荐量TCS。

核心结论

  • 很大比例的年轻成人AD患者治疗不足或未治疗。
  • 性别和疾病严重程度影响所研究药物的配取模式。

研究设计与样本

  • 基于人群的BAMSE出生队列24年随访的横断面研究,链接国家药品登记配取数据(n=2912)。
  • AD与 socioeconomic status 由问卷定义,疾病严重程度由临床检查和患者导向湿疹测量问卷确定。

主要发现

  • 年轻成人AD患病率为17.7%(n=516),其中45.5%在研究期间(2016年1月至2019年6月)至少配取一种AD治疗药物。
  • 外用糖皮质激素(TCS)最常见(32.9%),其次为润肤剂(21.7%)。
  • 男性配取TCS比例高于女性(39.0% vs. 29.1%,p=0.020)。
  • 中重度AD患者配取TCS比例高于轻度患者(52.6% vs. 35.3%,p=0.026)。
  • 男性(adj.OR 1.54,95%CI 1.06-2.34)和中重度AD(adj.OR 2.62,95%CI 1.59-4.31)与TCS配取相关。

关键数值与推荐

  • 无人配取推荐量的润肤剂。
  • 轻度AD中不足5人配取推荐量的TCS。

临床怎么用

  • 临床应关注年轻成人AD治疗不足问题,尤其是女性和轻度患者。
  • 需加强润肤剂和轻度AD患者TCS的规范使用与配取。

局限性

  • 横断面设计无法推断因果关系。
  • 配取数据可能不完全反映实际用药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atopic dermatitis (AD) affects individuals of all ages, and the first-line treatment are emollients and topical corticosteroids. There is insufficient knowledge about factors possibly affecting the drug utilization of young adults with AD. OBJECTIVES: To describe the drug utilization of young adults with AD in relation to sex, socio-economic status and disease severity. METHODS: A cross-sectional study based on the 24-year follow-up from the population-based BAMSE (Children, Allergy, Milieu, Stockholm, Epidemiology Survey) birth cohort linked with dispensing data from the National Drug Register (n = 2912). Self-reported AD and socio-economic status were defined from questionnaire data and disease severity was determined through the clinical examination and Patient-Oriented Eczema Measure questionnaire. RESULTS: The prevalence of AD in young adults was 17.7% (n = 516) and 45.5% of them were dispensed at least one drug for the treatment of AD during the study period (January 2016 to June 2019). Topical corticosteroids (TCS) were the most common drugs (32.9%) followed by emollients (21.7%). A larger proportion of men were dispensed TCS than women (39.0% vs. 29.1%: p-value = 0.020). A larger proportion of young adults with moderate-to-severe AD were dispensed TCS than those with mild AD (52.6% vs. 35.3%: p-value = 0.026). No one was dispensed the recommended amount of emollients and less than five individuals were dispensed the recommended amount of TCS for mild disease. Male sex (adj.OR 1.54, 95% CI 1.06-2.34) and moderate-to-severe AD (adj.OR 2.62, 95% CI 1.59-4.31) were associated with dispensation of TCS. CONCLUSIONS: A large proportion of young adults with AD was undertreated or untreated. Sex and disease severity did affect the dispensing patterns of investigated drugs.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Carmanius PL, Lundin S, Ödling M, et al. Drug utilization among young adults with atopic dermatitis: Influence of sex, socio-economic status and disease severity. J Eur Acad Dermatol Venereol. 2024. PMID: 38709168. doi:10.1111/jdv.20076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。